A 25-trial meta-analysis found an average loss of 3.7 kg ( 8 lbs) roughly 34 % of starting body weight over 852 weeks compared with placebo (PubMed 2024)
The study found that discontinuing semaglutide two weeks before surgery lowered a patient's risk for these complications
Bradt P, Spackman E, Synnott PG, Chapman R, Beinfeld M, Rind DM, and Pearson SD
Avoid exposure to extreme temperatures and do not use harsh chemicals for cleaning
Maximum Chronic Anti-Obesity Maintenance: Acts as the definitive long-term therapeutic plateau to maintain a lean body and permanently suppress adipose tissue expansion
The STEP trials showed sustained weight loss maintenance when patients remained on therapy, with some individuals achieving even greater reductions through consistent dosing and lifestyle support